Related Experiment Video
Updated: Aug 12, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Anaphylaxis to carboplatin following multiple previous uncomplicated courses
A K Sood1, M S Gelder, S W Huang
1Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville 32610-0294, USA.
Hypersensitivity reactions to carboplatin, though rare, can be life-threatening. Prompt identification of the causative agent through skin testing is crucial for managing anaphylaxis during platinum-based chemotherapy.
Area of Science:
- Oncology
- Clinical Pharmacology
- Allergy and Immunology
Background:
- Platinum-based chemotherapy agents like cisplatin and carboplatin are widely used in cancer treatment.
- Hypersensitivity reactions (HSRs) to platinum compounds, while uncommon, pose significant clinical challenges.
- Anaphylaxis is a severe, potentially fatal HSR that necessitates careful management.
Observation:
- A case report details a patient experiencing an anaphylactic reaction to carboplatin.
- The patient had a history of prior treatment with both cisplatin and carboplatin.
- This highlights the potential for cross-reactivity or cumulative sensitization.
Findings:
- Hypersensitivity reactions to carboplatin can occur even after multiple prior administrations.
- Skin testing can be a valuable diagnostic tool to identify the specific platinum agent responsible for HSRs.
- Early recognition and intervention are critical for patient safety.
Implications:
- Close patient monitoring during chemotherapy is essential for detecting HSRs promptly.
- Diagnostic skin testing should be considered in patients with suspected platinum-induced anaphylaxis.
- This case underscores the importance of individualized treatment strategies and vigilant patient care in oncology.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Related Concept Videos
Allergic Drug Reactions
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Drug Toxicity: Allergic Reactions
Allergic Reactions: Anaphylaxis
Hypersensitivity Reactions: Cytolytic Reactions
Drug toxicity: Idiosyncratic Reactions